Literature DB >> 10231420

Clear cell chondrosarcoma: a pathological and immunohistochemical study.

F Masui1, S Ushigome, K Fujii.   

Abstract

AIM: Clear cell chondrosarcoma (CCC) is a rare malignant cartilaginous neoplasm of bone. CCC is characterized by clear cells (CCC cells), osteoclasts and osteoblasts. Many important questions concerning the varied histological features of CCC, and the interactions between CCC cells and coexisting osteoclasts and osteoblasts have not been fully investigated and remain controversial. The aim of this study is to clarify and explain the varied histological features and the possible interaction between tumour cells (CCC cells) and stromal cells such as osteoclasts and osteoblasts. METHODS AND
RESULTS: Four cases of CCC were histologically and immunohistochemically studied in order to elucidate the biological nature and histological characteristics. A comparative study with chondroblastoma and grade I conventional chondrosarcoma (CC) was also performed. S100 protein and type II collagen were expressed in CCC cells, chondroblastoma cells and CC cells. CD68 and matrix metalloproteinase-9 were expressed in coexisting histiocytes and osteoclasts. Parathyroid hormone-like protein (PTH-LP) was expressed in histiocytes, osteoclasts, osteoblasts, chondroblastoma cells and CCC cells. Platelet-derived growth factor (PDGF) and its receptor (PDGF-R) were observed in osteoblasts, chondroblastoma cells and CCC cells. However, PTH-LP, PDGF and PDGF-R were not expressed in CC cells. PCNA (proliferating-cell nuclear antigen) was expressed more intensely in CCC than in chondroblastoma.
CONCLUSION: These observations suggest that CCC cells trigger the varied histological changes in association with several cytokines. The difference of PCNA expression between CCC and chondroblastoma seemed to be related to the biological difference between the two tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231420     DOI: 10.1046/j.1365-2559.1999.00656.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

1.  Clear cell chondrosarcoma proximal femur with secondary aneurysmal component - A rarity.

Authors:  N S Datt; C N S Mounika; Kopuri Ravi Kiran; D Ranga Rao; V Sandeep
Journal:  J Clin Orthop Trauma       Date:  2017-02-16

2.  Clear cell chondrosarcoma with secondary aneurysmal bone cyst changes.

Authors:  Timothy Tay; Steven Bak Siew Wong; Kesavan so Sittampalam; Denny Tjiauw Tjoen Lie
Journal:  Singapore Med J       Date:  2014-03       Impact factor: 1.858

Review 3.  RAGE and its ligands in bone metabolism.

Authors:  Zheng Zhou; Wen-Cheng Xiong
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

4.  Spinal chondrosarcoma: a review.

Authors:  Pavlos Katonis; Kalliopi Alpantaki; Konstantinos Michail; Stratos Lianoudakis; Zaharias Christoforakis; George Tzanakakis; Apostolos Karantanas
Journal:  Sarcoma       Date:  2011-03-08

Review 5.  Clear cell chondrosarcoma of the head and neck.

Authors:  Sepideh Mokhtari; Abbas Mirafsharieh
Journal:  Head Neck Oncol       Date:  2012-04-20

6.  An unusual case of clear cell chondrosarcoma with very late recurrence and lung metastases, 29 years after primary surgery.

Authors:  Minna Laitinen; Jyrki Nieminen; Toni-Karri Pakarinen
Journal:  Case Rep Orthop       Date:  2014-07-20

7.  Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature.

Authors:  Alexander Klein; Felix Tauscher; Christof Birkenmaier; Andrea Baur-Melnyk; Thomas Knösel; Volkmar Jansson; Hans Roland Dürr
Journal:  J Bone Oncol       Date:  2019-10-31       Impact factor: 4.072

8.  Primary clear cell chondrosarcoma of the spine: a case report of a rare entity and a review of the literature.

Authors:  Nikolaos A Paidakakos; Aristides Rovlias; Evaggelos Rokas; Spyridon Theodoropoulos; Patroklos Katafygiotis
Journal:  Case Rep Oncol Med       Date:  2012-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.